Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines-Reference-Cited by-同舟云学术

Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines

Published:2018-04-26 Issue:2 Volume:4 Page:169-183
ISSN:2352-3727
Container-title:Bladder Cancer
language:
Short-container-title:BLC

Author:

Zuiverloon Tahlita C.M.¹²³,de Jong Florus C.¹⁴,Costello James C.³⁵,Theodorescu Dan²³⁵

Affiliation:

1. Department of Urology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands

2. Department of Surgery (Urology), University of Colorado Anschutz Medical Campus, Aurora, CO, USA

3. University of Colorado Comprehensive Cancer Center, Aurora, CO, USA

4. Department of Pathology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands

5. Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA

Publisher

IOS Press

Subject

Urology,Oncology

Reference114 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. Ferlay JSI , Dikshit R , Eser S , Mathers C , Rebelo M , Parkin DM , Forman D , Bray F . Estimated cancer incidence, mortality and prevalance worldwide in 2012 by WHO international agency for research on cancer. Int J Cancer. 2015.

3. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials;Sylvester;Eur Urol,2006

4. Curative treatment for muscle invasive bladder cancer in elderly patients: A systematic review;Fonteyne;Eur Urol

5. What we have learned from urinary bladder cancer models;Bernardo;Journal of Cancer Metastasis and Treatment,2016

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and characterization of cellulose nanocrystals/Gd2O3 nanocomposite as a dual-mode contrast agent for MRI via gamma-ray irradiation;Radiation Physics and Chemistry;2024-08

2. Effects of combined radiotherapy with immune checkpoint blockade on immunological memory in luminal-like subtype murine bladder cancer model;Cancer Biology & Therapy;2024-06-11

3. New synergistic combination therapy approaches with HDAC inhibitor quisinostat, cisplatin or PARP inhibitor talazoparib for urothelial carcinoma;Journal of Cellular and Molecular Medicine;2024-05

4. Lysine Methyltransferase 9 (KMT9) Is an Actionable Target in Muscle-Invasive Bladder Cancer;Cancers;2024-04-17

5. Near-infrared photoimmunotherapy targeting Nectin-4 in a preclinical model of bladder cancer;Cancer Letters;2024-03